Immunoassays

Nanogen’s Portfolio of Immunoassay Products

Nanogen is developing a portfolio of advanced immunoassay products focused on cardiac-related health conditions and currently has a complete range of ELISA RUO test kits.

Our Point-of-Care Diagnostics Division has developed a rapid quantitative test for NT-proBNP as an aid in diagnosis of Congestive Heart Failure. This product has been cleared by FDA in the United States and is CE marked for sale in the European Union.